Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer
| dc.contributor.author | Salman, Tarık | |
| dc.contributor.author | Bilici, Ahmet | |
| dc.contributor.author | Arslan, Çağatay | |
| dc.contributor.author | Varol, Umut | |
| dc.contributor.author | Yıldız, İbrahim | |
| dc.contributor.author | Akyol, Murat | |
| dc.contributor.author | Yıldız, Yaşar | |
| dc.contributor.author | Küçükzeybek, Yüksel | |
| dc.contributor.author | Alacacıoğlu, Ahmet | |
| dc.contributor.author | Yılmaz, Uğur | |
| dc.date.accessioned | 2020-08-13T08:51:47Z | |
| dc.date.available | 2020-08-13T08:51:47Z | |
| dc.date.issued | 2016 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.citation | Salman, T., Bilici, A., Arslan, Ç., Varol, U., Yıldız, İ., Akyol, M. ... Yılmaz, U. (2016). Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer. Gastrointestinal Cancers Symposium. San Francisco, California, January 21-23, 2016. https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615 | |
| dc.identifier.doi | 10.1200/jco.2016.34.4_suppl.615 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issn | 1527-7755 | |
| dc.identifier.issue | 4 | |
| dc.identifier.uri | https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/5719 | |
| dc.identifier.volume | 34 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | American Society of Clinical Oncology | |
| dc.relation.ispartof | Gastrointestinal Cancers Symposium | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Thrombin | |
| dc.subject | Prothrombin | |
| dc.subject | Colorectal Cancer | |
| dc.title | Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer | |
| dc.type | Conference Object |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama:











